Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8TBJ4

Entry ID Method Resolution Chain Position Source
AF-Q8TBJ4-F1 Predicted AlphaFoldDB

221 variants for Q8TBJ4

Variant ID(s) Position Change Description Diseaes Association Provenance
TCGA novel 1 M>? Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374368095
rs1404237527
2 A>T No ClinGen
gnomAD
rs75832966
CA5160249
3 V>A No ExAC
gnomAD
ClinGen
rs75832966
CA197262535
3 V>G No ClinGen
ExAC
gnomAD
rs1458167241
CA374368102
3 V>L No ClinGen
TOPMed
gnomAD
rs928324444
CA197262536
6 N>D No ClinGen
TOPMed
CA374368121
rs1588062955
6 N>S No Ensembl
ClinGen
CA374368130
rs1176842247
7 T>S No ClinGen
TOPMed
gnomAD
CA5160252
rs200860367
9 R>Q No ExAC
TOPMed
gnomAD
ClinGen
rs41296085
CA5160253
12 S>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA197262537
rs1023937851
14 I>L No Ensembl
ClinGen
rs747599995
CA5160257
16 C>Y No ClinGen
ExAC
gnomAD
rs146000696
CA5160259
18 I>M No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA374368203
rs1353992366
18 I>T No ClinGen
TOPMed
CA374368200
rs1301352674
18 I>V No ClinGen
TOPMed
gnomAD
TCGA novel 21 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1251928208
CA374368241
22 L>F No Ensembl
ClinGen
rs748916921
CA5160279
24 I>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ExAC
gnomAD
ClinGen
NCI-TCGA
CA5160280
rs770579216
25 M>V No ClinGen
ExAC
gnomAD
rs1465004638
CA374368270
26 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No TOPMed
ClinGen
NCI-TCGA
CA5160281
rs778577480
28 T>A No ClinGen
ExAC
gnomAD
rs1186319539
CA374368283
29 V>L No ClinGen
gnomAD
CA374368295
rs1269459646
31 L>F No TOPMed
ClinGen
rs1406465588
CA374368304
32 A>V No gnomAD
ClinGen
TCGA novel 37 C>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374368339
rs1451048683
37 C>G No TOPMed
gnomAD
ClinGen
CA374368338
rs1451048683
37 C>R No ClinGen
TOPMed
gnomAD
rs568942556
CA5160285
37 C>Y No ClinGen
1000Genomes
ExAC
gnomAD
rs769782936
CA5160286
38 T>S No ExAC
gnomAD
ClinGen
rs1291219087
CA374368370
COSM3786073
41 F>L pancreas [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA374368378
rs1588104643
42 Q>H No ClinGen
Ensembl
CA374368386
rs1381022673
44 H>D No ClinGen
gnomAD
TCGA novel 44 H>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA197271861
rs867093135
47 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs117491062
CA197271863
52 D>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs868474605
CA197271862
52 D>N No ClinGen
Ensembl
rs368320785
CA5160290
53 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 58 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5160291
rs759889251
58 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA374368489
rs759889251
58 P>T No ClinGen
ExAC
TOPMed
gnomAD
rs866810351
CA197271864
61 G>E No ClinGen
Ensembl
CA374368514
rs1239610230
62 T>A No ClinGen
gnomAD
TCGA novel 62 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374368569
rs1564022795
69 T>N No ClinGen
Ensembl
CA374368579
rs763545864
71 L>V No ExAC
TOPMed
gnomAD
ClinGen
CA5160296
rs753323821
72 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA5160297
rs756874307
73 L>F No ExAC
gnomAD
ClinGen
rs778618938
CA5160298
74 Y>C No ExAC
TOPMed
gnomAD
ClinGen
rs778618938
CA374368597
74 Y>F No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 75 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1310652122
CA374368620
78 A>P No ClinGen
gnomAD
TCGA novel 78 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs372236848
CA5160299
79 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs754637630
CA5160301
82 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs746971581
CA5160302
82 T>I No ExAC
gnomAD
ClinGen
rs1256151072
CA374368646
83 A>T No ClinGen
TOPMed
rs768569090
CA5160303
84 I>V No ClinGen
ExAC
gnomAD
CA5160322
rs758081307
87 I>F No ClinGen
ExAC
gnomAD
CA374368689
rs758081307
87 I>L No ExAC
gnomAD
ClinGen
rs1436874410
CA374368695
88 G>R No ClinGen
TOPMed
rs1166917256
CA374368716
91 S>P No ClinGen
TOPMed
gnomAD
CA374368715
rs1166917256
91 S>T No TOPMed
gnomAD
ClinGen
rs1588111198
CA374368724
92 M>T No Ensembl
ClinGen
CA197273561
rs201250597
92 M>V No ClinGen
TOPMed
gnomAD
rs201289914
CA5160324
95 I>V No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
rs754925689
CA5160325
98 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs781184153
CA5160326
99 R>G No ClinGen
ExAC
gnomAD
CA197273564
rs866615719
101 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA374368787
rs866615719
101 S>Y No ClinGen
gnomAD
TCGA novel 103 I>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs774363945
CA5160329
103 I>T No ExAC
gnomAD
ClinGen
CA374368800
rs1219699759
104 A>T No gnomAD
ClinGen
CA374368811
rs1333350599
105 Q>R No gnomAD
ClinGen
CA197273565
rs370046405
108 T>I No ESP
TOPMed
ClinGen
CA374368836
rs1212081542
109 I>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
rs772217528
CA5160331
109 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA5160332
rs775845832
110 L>V No ClinGen
ExAC
gnomAD
CA5160334
rs769113387
112 G>E No ClinGen
ExAC
gnomAD
rs1260639911
CA374368851
112 G>R No ClinGen
gnomAD
TCGA novel 113 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA197273567
rs868578200
119 P>L No Ensembl
ClinGen
rs1588111267
CA374368901
119 P>T No Ensembl
ClinGen
CA374368910
rs1276194344
120 L>S No ClinGen
gnomAD
rs1443413009
CA374368915
121 L>F No TOPMed
ClinGen
CA197273568
rs924333774
122 R>Q No gnomAD
ClinGen
CA374368929
rs1400238835
123 R>S No ClinGen
gnomAD
CA374368942
rs1362751037
125 I>M No ClinGen
gnomAD
rs761281978
CA5160336
COSM752277
125 I>V lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ExAC
TOPMed
gnomAD
ClinGen
cosmic curated
NCI-TCGA
rs764865317
CA5160337
127 F>S No ExAC
gnomAD
ClinGen
rs767375015
CA5160361
130 V>L No ExAC
gnomAD
ClinGen
CA5160362
rs752369015
132 A>T No ExAC
gnomAD
ClinGen
rs1400457456
CA374368999
132 A>V No ClinGen
gnomAD
rs1564033853
CA374369017
135 L>H No ClinGen
Ensembl
CA5160363
rs375650714
135 L>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5160364
rs777674634
137 A>T No ExAC
TOPMed
gnomAD
ClinGen
CA5160365
rs750570003
140 I>V No ExAC
gnomAD
ClinGen
CA5160367
rs374506978
144 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 144 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 145 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs975934254
CA197276248
147 V>A No ClinGen
Ensembl
CA374369102
rs1564033868
148 V>A No Ensembl
ClinGen
CA5160369
rs149405756
148 V>L No ClinGen
1000Genomes
ExAC
gnomAD
CA374369119
rs1393379158
151 H>P No TOPMed
ClinGen
CA374369118
rs1173532569
151 H>Y No ClinGen
TOPMed
gnomAD
CA374369148
rs1378260774
155 Y>F No gnomAD
ClinGen
rs773821062
CA5160373
161 K>* No ClinGen
ExAC
CA5160374
rs150814920
162 P>L No ESP
ExAC
gnomAD
ClinGen
rs1283268204
CA374369193
162 P>S No ClinGen
Ensembl
rs773692925
CA5160376
163 N>D No ExAC
TOPMed
gnomAD
ClinGen
rs759232206
CA5160377
164 Y>C No ClinGen
ExAC
gnomAD
rs767021755
CA5160378
165 T>P No ExAC
TOPMed
gnomAD
ClinGen
CA5160379
rs775413062
165 T>S No ExAC
gnomAD
ClinGen
rs760459469
CA5160380
166 S>R No ExAC
gnomAD
ClinGen
CA197276251
rs3209400
170 Q>* No Ensembl
ClinGen
rs764061295
CA5160381
171 A>V No ExAC
gnomAD
ClinGen
rs1364632590
CA374369261
172 H>Q No ClinGen
TOPMed
rs1193151487
CA374369265
173 H>Y No gnomAD
ClinGen
CA5160384
rs530545562
174 Q>R No ClinGen
1000Genomes
ExAC
gnomAD
COSM218967
rs751532084
CA5160385
178 N>S pancreas [Cosmic] No ExAC
gnomAD
ClinGen
cosmic curated
rs1452979767
CA374369311
179 G>E No ClinGen
TOPMed
rs998355165
CA197276252
180 N>I No ClinGen
TOPMed
TCGA novel 180 N>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 182 C>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1401739536
CA374369352
185 D>G No ClinGen
gnomAD
rs768378346
CA197276253
COSM1458948
186 L>M large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No Ensembl
ClinGen
cosmic curated
NCI-TCGA
CA374369360
rs1282708268
187 E>K No ClinGen
TOPMed
rs756644661
CA197276254
188 V>M No Ensembl
ClinGen
CA374369377
rs1204069043
189 I>T No ClinGen
TOPMed
CA374369373
rs1461331206
189 I>V No gnomAD
ClinGen
rs1388171428
CA374369403
193 R>Q No gnomAD
ClinGen
CA5160389
rs571135401
193 R>W No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
CA374369455
rs1318531360
201 A>T No gnomAD
ClinGen
rs1263782200
CA374369501
208 A>T No ClinGen
gnomAD
rs1489535473
CA374369507
209 L>I No TOPMed
gnomAD
ClinGen
rs771824283
CA5160395
211 A>V No ExAC
gnomAD
ClinGen
CA5160396
rs774975567
212 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA197276636
rs754779962
213 M>I No gnomAD
ClinGen
rs1300855496
CA374369572
216 T>I No ClinGen
gnomAD
rs1381272188
CA374369582
218 T>A No ClinGen
gnomAD
CA374369593
rs1308667603
219 I>M No ClinGen
gnomAD
rs1228752245
CA374369591
219 I>T No gnomAD
ClinGen
CA5160415
rs200667385
221 T>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ESP
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
CA5160414
rs200667385
221 T>M Variant assessed as Somatic; 4.628e-05 impact. [NCI-TCGA] No ESP
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
CA5160418
rs147722670
223 S>N No ClinGen
ESP
ExAC
gnomAD
CA374369624
rs1231232340
224 S>N No ClinGen
TOPMed
CA5160419
rs776464922
225 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No ExAC
gnomAD
ClinGen
NCI-TCGA
CA374369630
rs1208537784
225 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
rs1588122894
CA374369639
227 A>P No Ensembl
ClinGen
CA5160421
rs769808567
227 A>V No ExAC
gnomAD
ClinGen
CA374369661
rs1178515380
230 V>A No ClinGen
gnomAD
rs1159925949
CA374369679
233 L>H No ClinGen
gnomAD
CA197276639
rs201352342
234 G>R No ClinGen
Ensembl
rs1413492552
CA374369692
235 T>S No gnomAD
ClinGen
rs760990429
CA5160426
236 L>F No ExAC
TOPMed
gnomAD
ClinGen
rs760990429
CA374369694
236 L>V No ExAC
TOPMed
gnomAD
ClinGen
rs1316439434
CA374369699
237 C>G No TOPMed
ClinGen
TCGA novel 238 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374369706
rs1360638794
238 T>P No gnomAD
ClinGen
CA5160427
rs189030340
240 F>L No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
rs1321150074
CA374369739
243 G>A No ClinGen
TOPMed
TCGA novel 243 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750918337
CA5160431
246 R>Q No ExAC
gnomAD
ClinGen
rs367663778
CA5160430
246 R>W No ESP
ExAC
gnomAD
ClinGen
rs1330958739
CA374369759
247 V>I No TOPMed
gnomAD
ClinGen
rs746467901
CA374369775
249 E>G No ExAC
TOPMed
gnomAD
ClinGen
CA374369771
rs1281208258
249 E>K No ClinGen
gnomAD
rs746467901
CA5160434
249 E>V No ClinGen
ExAC
TOPMed
gnomAD
CA5160435
rs768359809
250 Y>C No ExAC
gnomAD
ClinGen
rs371486478
CA197276640
251 R>Q No ClinGen
ESP
CA5160436
rs780787669
251 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA5160438
rs769495669
255 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs1189046666
CA374369826
257 V>L No ClinGen
gnomAD
CA5160441
rs199633082
260 G>C No 1000Genomes
ExAC
gnomAD
ClinGen
CA374369844
rs199633082
260 G>S No ClinGen
1000Genomes
ExAC
gnomAD
CA374369864
rs1234856864
263 L>M No ClinGen
TOPMed
rs1169692729
CA374369881
266 A>T No gnomAD
ClinGen
CA5160443
rs760832752
269 L>M No ExAC
gnomAD
ClinGen
CA374248445
rs1307147972
272 G>E No TOPMed
ClinGen
rs777477569
CA5160477
273 M>I No ExAC
TOPMed
gnomAD
ClinGen
CA5160475
rs752191646
273 M>L No ExAC
gnomAD
ClinGen
CA5160476
rs755780295
273 M>T No ClinGen
ExAC
gnomAD
TCGA novel 274 C>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1368406232
CA374248501
277 H>R No ClinGen
TOPMed
rs1324816491
CA374248555
281 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA5160479
rs757098094
281 G>R No ExAC
gnomAD
ClinGen
rs778803378
CA5160480
COSM1103296
282 T>M Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ExAC
gnomAD
ClinGen
cosmic curated
NCI-TCGA
CA5160482
rs372382236
283 Q>R No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA196919449
rs866065187
284 G>E No ClinGen
Ensembl
CA374248595
rs1419348572
285 S>T No gnomAD
ClinGen
rs1296631806
CA374248626
288 K>E No ClinGen
TOPMed
gnomAD
CA374248639
rs376477018
289 P>S No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA5160484
rs376477018
289 P>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ESP
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
TCGA novel 292 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1333911204
CA374248673
292 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1045674628
CA196919510
293 D>E No ClinGen
TOPMed
gnomAD
rs1031778448
CA196919486
293 D>G No ClinGen
TOPMed
gnomAD
rs1238762922
CA374248701
294 P>H No gnomAD
ClinGen
rs371399190
CA5160486
294 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ESP
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
rs371399190
CA5160487
294 P>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs200604503
CA5160488
295 R>C Variant assessed as Somatic; 4.62e-05 impact. [NCI-TCGA] No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
rs41274977
CA5160489
295 R>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs760048467
CA5160490
296 G>E No ClinGen
ExAC
gnomAD
CA374248731
rs1440658982
297 V>E No ClinGen
gnomAD
CA5160492
rs752215412
298 P>L No ExAC
gnomAD
ClinGen
rs768054227
CA5160491
298 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1156932528
CA374248761
300 M>T No gnomAD
ClinGen
CA196919620
rs758925822
301 A>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA196919608
rs866850807
301 A>T No ClinGen
gnomAD
rs377300989
CA5160493
308 P>S No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA374248881
rs1172368348
311 T>P No gnomAD
ClinGen
rs1234596135
CA374248894
312 L>V No TOPMed
ClinGen
CA374248925
rs1400467866
314 A>V No TOPMed
gnomAD
ClinGen
rs749513889
CA5160504
317 H>Q No ExAC
TOPMed
gnomAD
ClinGen
rs771081264
CA5160505
318 S>F No ExAC
gnomAD
ClinGen
CA5160506
rs140912404
319 A>V No ESP
ExAC
TOPMed
gnomAD
ClinGen
TCGA novel 320 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5160508
rs772495204
321 M>V No ClinGen
ExAC
gnomAD
CA5160509
rs776044397
322 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA374249735
rs1225180391
323 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
COSM1319675
CA374249768
rs1355089096
325 T>I Variant assessed as Somatic; impact. haematopoietic_and_lymphoid_tissue [NCI-TCGA, Cosmic] No TOPMed
ClinGen
cosmic curated
NCI-TCGA
rs1283626316
CA374249772
326 T>R No gnomAD
ClinGen

No associated diseases with Q8TBJ4

1 regional properties for Q8TBJ4

Type Name Position InterPro Accession
domain Phosphatidic acid phosphatase type 2/haloperoxidase 128 - 274 IPR000326

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
  • Cell projection, neuron projection
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
neuron projection A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

2 GO annotations of molecular function

Name Definition
lipid phosphatase activity Catalysis of the reaction: a phospholipid + H2O = a lipid + phosphate.
phosphatidate phosphatase activity Catalysis of the reaction: a 1,2-diacylglycerol 3-phosphate + H2O = a 1,2-diacyl-sn-glycerol + phosphate.

4 GO annotations of biological process

Name Definition
nervous system development The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
phospholipid dephosphorylation The process of removing one or more phosphate groups from a phosphorylated lipid, any member of a group of substances soluble in lipid solvents but only sparingly soluble in aqueous solvents.
phospholipid metabolic process The chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O14495 PLPP3 Phospholipid phosphatase 3 Homo sapiens (Human) PR
Q99JY8 Plpp3 Phospholipid phosphatase 3 Mus musculus (Mouse) PR
Q8BFZ2 Plppr1 Phospholipid phosphatase-related protein type 1 Mus musculus (Mouse) PR
P97544 Plpp3 Phospholipid phosphatase 3 Rattus norvegicus (Rat) PR
Q6WAY2 Plppr1 Phospholipid phosphatase-related protein type 1 Rattus norvegicus (Rat) PR
A4II83 plppr1 Phospholipid phosphatase-related protein type 1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q6IQH6 plppr1 Phospholipid phosphatase-related protein type 1 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MAVGNNTQRS YSIIPCFIFV ELVIMAGTVL LAYYFECTDT FQVHIQGFFC QDGDLMKPYP
70 80 90 100 110 120
GTEEESFITP LVLYCVLAAT PTAIIFIGEI SMYFIKSTRE SLIAQEKTIL TGECCYLNPL
130 140 150 160 170 180
LRRIIRFTGV FAFGLFATDI FVNAGQVVTG HLTPYFLTVC KPNYTSADCQ AHHQFINNGN
190 200 210 220 230 240
ICTGDLEVIE KARRSFPSKH AALSIYSALY ATMYITSTIK TKSSRLAKPV LCLGTLCTAF
250 260 270 280 290 300
LTGLNRVSEY RNHCSDVIAG FILGTAVALF LGMCVVHNFK GTQGSPSKPK PEDPRGVPLM
310 320
AFPRIESPLE TLSAQNHSAS MTEVT